De novo AML with mutated RUNX1 have characteristic clinicopathologic features that include male predominance, higher frequency of SRSF2 and ASXL1 mutations, normal karyotype, and absent NPM1 mutations (68). The gene discussed is NPM1; the disease is acute myeloid leukemia.